OBJECTIVE To examine alteration of serum interleukin-6 and its clinical significance in burning mouth syndrome (BMS) patients. METHODS 48 BMS patients and 31 healthy controls participated in the study. Serum interleukin-6 was measured by means of ELISA. Hamilton rating scale of depression (HRSD) and visual analogue scale (VAS) were used to quantitate depressive status and pain levels of subje...

Background and aims: low level laser therapy (LLLT) has been used in the treatment of burning mouth syndrome (BMS) for recent years and the role of intervention has not proven accurately. We conducted a systematic review and meta-analysis to investigate the efficacy of low level laser therapy (LLLT) in the treatment of burning mouth syndrome (BMS). Methods: We performed a search on PubMed, Emba...

Burning Mouth Syndrome (BMS) is defined as a chronic orofacial pain syndrome, without evidence of mucosal lesions and other clinical signs of disease or laboratory abnormalities. Patients with BMS complain of burning pain in the mouth, xerostomia and taste disturbances. It is more common among women and the median age of occurrence is about 60 years. BMS may be primary or secondary to other dis...

BACKGROUND AND AIMS Burning mouth syndrome (BMS) is a chronic pain disorder characterized by a chief complaint of oral burning/pain with no clinically observable oral mucosal lesions. The prevalence of BMS has been reported to be 2.5-5.1% in the general population and several psychological disorders have been reported as associated or predisposing factors for BMS. The aim of this study was to d...